{"paper_id": "fa994c4585ad68547b8a9fd973109d183fe8b71e", "metadata": {"title": "Supplemental material", "authors": [{"first": "", "middle": [], "last": "Hernandez", "suffix": "", "affiliation": {}, "email": ""}]}, "abstract": [], "body_text": [{"text": "Genes listed in bold are homozygous, while those not in bold may be compound heterozygous or may occur on the same allele. a Gene that is predicted to be related to PIDs via a connectome analysis (Itan et al., 2013) . b Gene containing a stop-gain mutation.", "cite_spans": [{"start": 196, "end": 215, "text": "(Itan et al., 2013)", "ref_id": "BIBREF0"}], "ref_spans": [], "section": ""}], "bib_entries": {"BIBREF0": {"ref_id": "b0", "title": "The human gene connectome as a map of short cuts for morbid allele discovery", "authors": [{"first": "Y", "middle": [], "last": "Itan", "suffix": ""}, {"first": "S", "middle": ["Y"], "last": "Zhang", "suffix": ""}, {"first": "G", "middle": [], "last": "Vogt", "suffix": ""}, {"first": "A", "middle": [], "last": "Abhyankar", "suffix": ""}, {"first": "M", "middle": [], "last": "Herman", "suffix": ""}, {"first": "P", "middle": [], "last": "Nitschke", "suffix": ""}, {"first": "D", "middle": [], "last": "Fried", "suffix": ""}, {"first": "L", "middle": [], "last": "Quintana-Murci", "suffix": ""}, {"first": "L", "middle": [], "last": "Abel", "suffix": ""}, {"first": "J", "middle": ["L"], "last": "Casanova", "suffix": ""}], "year": 2013, "venue": "Proc. Natl. Acad. Sci. USA", "volume": "110", "issn": "", "pages": "5558--5563", "other_ids": {"DOI": ["10.1073/pnas.1218167110"]}}}, "ref_entries": {"FIGREF0": {"text": "VirScan analysis of specific anti-viral antibodies detected in patient sera. Positive identification requires antibodies recognizing at least three epitopes specific to a given virus. Positive cells are colored black, whereas negative cells are colored light gray.", "latex": null, "type": "figure"}, "FIGREF1": {"text": "Exon trapping scheme. Diagram of IRF9 mRNA in the region containing exon 7 inserted into the pSPL3 exon trapping system with or without the c.991G>A mutation indicated with a vertical red line. Exons are depicted as boxes while noncoding sequences are lines. Primers used in cDNA sequencing are demonstrated, and the nucleotide lengths of the features are shown in parenthesis. HIV-TAT sequences present in the pSPL3 vector are colored gray and brown.", "latex": null, "type": "figure"}, "TABREF0": {"text": "Immunophenotyping", "latex": null, "type": "table", "html": "<html><body><table><tr><td>Parameter </td><td>Patient values Normal range for 2-5 yr old\n</td></tr><tr><td>Total lymphocytes (cells/\u00b5l) </td><td>4,100\n</td><td>\u00a0</td></tr><tr><td>T lymphocytes\n</td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>CD3+ (%) </td><td>57 </td><td>56-75\n</td></tr><tr><td>CD3+ </td><td>2,337 </td><td>1,400-3,700\n</td></tr><tr><td>CD4+ (%) </td><td>32 </td><td>28-47\n</td></tr><tr><td>CD4+ </td><td>1,312 </td><td>700-2,200\n</td></tr><tr><td>CD8+ (%) </td><td>18 </td><td>16-30\n</td></tr><tr><td>CD8+ </td><td>738 </td><td>490-1,300\n</td></tr><tr><td>CD45RO+/CD4+ (%) </td><td>36.5\n</td><td>\u00a0</td></tr><tr><td>CD45RA+/CD4+ (%) </td><td>63.5 </td><td>73-86\n</td></tr><tr><td>CD31+/CD4+ (%) </td><td>58\n</td><td>\u00a0</td></tr><tr><td>CD31+/CD45RA/CD4+ (%) </td><td>48 </td><td>57-65\n</td></tr><tr><td>B lymphocytes\n</td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>CD21++CD24+/CD19+ (%) </td><td>87\n</td><td>\u00a0</td></tr><tr><td>CD27+ IgD+/CD19+ (%) </td><td>4 </td><td>4.6-16.3\n</td></tr><tr><td>CD27\u2212 IgD+/CD19+ (%) </td><td>86 </td><td>69.2-90.5\n</td></tr><tr><td>CD24++CD38++/CD19+ (%) </td><td>4\n</td><td>\u00a0</td></tr><tr><td>CD24++D38++CD27\u2212IgD+/CD19+ </td><td>5\n</td><td>\u00a0</td></tr><tr><td>(%)\n</td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>CD24\u2212CD38++/CD19+ (%) </td><td>0.2\n</td><td>\u00a0</td></tr><tr><td>CD21\u2212CD38\u2212/100 lymphocytes </td><td>3\n</td><td>\u00a0</td></tr><tr><td>CD19+ (%) </td><td>32 </td><td>7.6-28.2\n</td></tr><tr><td>CD19+ </td><td>1,312 </td><td>319-1,244\n</td></tr><tr><td>CD27+/CD19+ (%) </td><td>10 </td><td>7-24.3\n</td></tr><tr><td>CD27+ IgD\u2212/CD19+ (%) </td><td>6 </td><td>2.7-12.5\n</td></tr><tr><td>Natural killer lymphocytes\n</td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>CD16+CD56+ (%) </td><td>9 </td><td>4-17\n</td></tr><tr><td>CD16+CD56+ </td><td>369 </td><td>130-720\n</td></tr><tr><td>Diverse T lymphocyte markers\n</td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>CCR7\u2212CD45RA+/CD8+ (%) </td><td>13 </td><td>16-28\n</td></tr><tr><td>CCR7+CD45RA+/CD8+ (%) </td><td>52 </td><td>52-68\n</td></tr><tr><td>CCR7\u2212CD45RA\u2212/CD8+ (%) </td><td>29 </td><td>11-20\n</td></tr><tr><td>CCR7+CD45RA\u2212/CD8+ </td><td>6 </td><td>3-4\n</td></tr></table></body></html>"}}, "back_matter": []}